Gyrus Acmi, Inc.

Gyrus Acmi, Inc., operating as Olympus Surgical Technologies America, is a for-profit medical device manufacturer and a subsidiary of Olympus Corporation that specializes in advanced medical technologies and surgical equipment. The company, headquartered in Redmond, Washington, serves as a prime contractor to federal agencies, primarily supplying specialized surgical implants and valve systems to support healthcare services for veterans, military personnel, and medical research institutions. With a registered SAM.gov status through October 14, 2026, Gyrus Acmi demonstrates consistent capability in providing critical medical equipment that aligns with federal healthcare initiatives and research programs.

The company has secured numerous federal contract awards exclusively through the Department of Veterans Affairs and related entities, along with the Defense Health Agency and National Institutes of Health Clinical Center. Gyrus Acmi's primary offering consists of IB Valve Systems, Spiration Valve Systems, emergency interbronchial valves, and various surgical implants delivered through firm fixed-price purchase orders. The company has fulfilled contracts across multiple Veterans Integrated Service Networks, including VISN 2, VISN 12, VISN 16, VISN 17, and VISN 20, demonstrating geographic reach and sustained vendor relationships. Award values have ranged from approximately $6,750 to $43,050 per individual purchase order, with no set-aside designations applied to any awards. The contracts support respiratory and surgical applications critical to veteran care, and the company has maintained consistent vendor status with no reported subcontractors or partnerships on federal awards. Notable contracts include emergency procurements for specialized valve systems, prosthetic implant orders, and scientific supplies supporting the NIH Clinical Center's research mission.

Gyrus Acmi holds a single-award Blanket Purchase Agreement with the Department of Veterans Affairs, specifically through Veterans Integrated Service Network 16, awarded on January 22, 2025, with a ceiling value of $249,999.99 and a performance period extending through January 21, 2030. This BPA provides a framework for flexible procurement of IB Valve Surgical Implants and related orders to support veteran healthcare services across the VA system. The BPA mechanism enables multiple task order calls under a pre-negotiated contract vehicle, with individual purchase orders expected to range from $6,750 to $43,050, consistent with historical award patterns. The company has already executed at least one significant call order under this BPA—a $42,900 award on December 1, 2025, for IB Valve surgical implants scheduled for completion by November 30, 2026. This overarching agreement positions Gyrus Acmi as a primary strategic supplier of specialized surgical implant technologies within the VA's procurement ecosystem and demonstrates the vendor's established credibility and performance capability in federal healthcare contracting.